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Structural Basis for the Antibiotic Activity
of Ketolides and Azalides
interactions within the PTAR. Although organisms can
tolerate few modifications in the PTAR without loss of
viability, several mutations or posttranslational modifi-
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1Max-Planck-Research Unit cations, leading to antibiotic-resistant microorganisms,
have been identified (reviewed in [4, 5]).for Ribosomal Structure
22603 Hamburg The rapid emergence of drug resistance in many
pathogenic bacteria intensified the search for new anti-Germany
2 Weizmann Institute microbial agents, which led to the development of chem-
ically modified macrolides, namely, the azalides [6] and76100 Rehovot
Israel ketolides [7]. Azalide antimicrobials are semisynthetic
derivatives of erythromycin with a 15-membered lactone3 Max-Planck-Institute for Molecular Genetics
14195 Berlin ring (Figure 1). The insertion of a methyl-substituted
nitrogen in the lactone ring increases the basicity, re-Germany
sulting in improved acid stability and bioavailability com-
pared with erythromycin. Ketolides are a novel class of
antibiotics derived from 14-membered macrolides bySummary
substitution of the cladinose sugar by a 3-keto group
(Figure 1).The azalide azithromycin and the ketolide ABT-773,
which were derived by chemical modifications of In gram-negative bacteria, resistance to macrolides
is frequently related to the impermeability of the cellularerythromycin, exhibit elevated activity against a num-
ber of penicillin- and macrolide-resistant pathogenic outer membrane because of the hydrophobic nature
of macrolides [8–10]. Clinically acquired resistance tobacteria. Analysis of the crystal structures of the large
ribosomal subunit from Deinococcus radiodurans com- macrolides is mostly due to the production of methyl-
ases by a group of genes termed the erm genes. Azithro-plexed with azithromycin or ABT-773 indicates that,
despite differences in the number and nature of their mycin and ABT-773 were designed to overcome these
obstacles and were found to yield a higher efficiencycontacts with the ribosome, both compounds exert
their antimicrobial activity by blocking the protein exit against some gram-negative respiratory pathogens,
such as Haemophilus influenzae and enteric bacilli, in-tunnel. In contrast to all macrolides studied so far, two
molecules of azithromycin bind simultaneously to the cluding Shigella and Salmonella species [11–13]. Azith-
romycin has the additional advantage of prolongedtunnel. The additional molecule also interacts with two
proteins, L4 and L22, implicated in macrolide resis- tissue levels, offering short treatment regimes and im-
proved tolerance [14]. The induction of the productiontance. These studies illuminated and rationalized the
enhanced activity of the drugs against specific macro- of the methylases is, furthermore, suppressed for mac-
rolides like josamycin [15, 16] and ketolides like ABT-lide-resistant bacteria.
773 [17].
We present here the crystal structures of the largeIntroduction
ribosomal subunit of D. radiodurans (D50S) in complex
with the azalide azithromycin and the ketolide ABT-773.Ribosomes are large, bipartite nucleoprotein complexes
responsible for the accurate translation of genetic mes- The results exhibit the common features of ribosome-
drug interactions among macrolides, azalides, and ke-sages. The peptide bond formation is catalyzed in the
peptidyl transferase center (PTC) of the large ribosomal tolides and elucidate the success of structural modifica-
tions of the macrolides to partially overcome antibioticsubunit (50S in prokaryotes). The region of the structure
of the 50S subunit defining the catalytic core and the resistances. The crystallographic analyses of the bind-
ing modes of macrolides, azalides, and ketolides to theentrance to the ribosomal exit tunnel is referred to as
the peptidyl transferase-associated region (PTAR), in 50S ribosomal subunit provide an excellent tool for un-
derstanding how these antibiotics defeat some of theanalogy to the GTPase-associated region [1].
The integrity of the PTAR is crucial for protein biosyn- resistance mechanisms, a crucial step in the develop-
ment of new drugs, based on modifications of the mac-thesis and, hence, for the viability of all organisms, which
makes the PTAR a primary target for several classes rolide class of antibiotics.
of antibiotics. Crystal structures of complexes of 50S
ribosomal subunits from Deinococcus radiodurans [2] Results
and Haloarcula marismortui [3] demonstrated that, par-
ticularly, macrolides, lincosamides, and chloramphenicol The crystal structures of the D50S ribosomal subunit
in complex with azithromycin and ABT-773 extend theachieve their antimicrobial activity through alterations or
previously reported results on ribosome-macrolide
complexes to two new classes of antibiotics, namely,*Correspondence: yonath@mpgars.desy.de
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C3-ketone, ABT-773 has a quinolylallyl at the C6-O posi-
tion and a cyclic carbamate group at C11,12 inserted in
the 14-membered lactone ring (Figure 1). The cladinose
sugar was originally believed to be important for the
binding of the macrolides, but our previous studies of
macrolide-ribosome interactions indicated the compar-
atively low contribution of the cladinose moiety to the
binding of the macrolides on the 50S subunit [2].
The quinolylallyl group is tethered to the macrolide
skeleton through a rather flexible linker, which allows
the moiety to occupy different spatial positions. The
inherent flexibility is reflected by the electron density of
the quinolylallyl group, which appears to be less well
resolved (Figure 2A). The position of the quinolylallyl
best fitting the electron density allows N3 of the quinoly-Figure 1. Chemical Structures of ABT-773 and Azithromycin
lallyl to form a hydrogen bond with O2 of C803DRABT-773, left; azithromycin, right.
(U790EC) of domain II (Figures 2B and 2C). This is in
agreement with biochemical experiments indicating that
azalides and ketolides. The crystals of the complexes domain II might be involved in the binding of some of the
were obtained by crystallization of the 50S subunit in ketolides [18, 22]. Throughout the structures of different
the presence of micromolar concentrations of ABT-773 complexes of the 50S subunit from D. radiodurans, we
or azithromycin (see Experimental Procedures). Data observed only a few significant variations. Among them
have been collected for both complexes to a resolution is the loop connecting helices 32 and 35a (Figures 3
of 3.5 A˚ and 3.2 A˚, respectively (Table 1). The electron and 5D), which includes C803DR (U790EC). The base of
density maps for azithromycin and ABT-773 allowed an C803DR (U790EC) appears shifted by about 2 A˚ toward
unambiguous determination of the binding sites of both ABT-773 compared with the native structure and by
antibiotics. The interactions of ABT-773 with specific about 8 A˚ compared with the complex with azithromycin
nucleotides of the multibranched loop of domain V of (see below), thus reflecting the inherent flexibility of this
23S rRNA are rather similar to those of erythromycin, region.
but additional contacts with domains II and IV lead to Another region of 23S rRNA exhibiting conformational
a tighter binding. changes through the interaction with ABT-773 is the
Azithromycin is, so far, the only one of these classes single strand composed of rRNA bases 2585–2590DR
of antibiotics that revealed an unexpected secondary (2606–2611EC) (Figures 3 and 5D). U2588DR (U2609EC)
binding site. The primary site is located in a position of domain V of 23S rRNA forms a network of hydrophobic
and orientation quite similar to that observed for erythro- interactions with the carbamate group of ABT-773. To-
mycin or ABT-773. The second molecule was found to gether with the hydrogen bond between O4 of U2588DR
be in direct contact with the primary binding site, both (U2609EC) and N2 of the carbamate group, these inter-
sites blocking the path of the nascent chain. The second actions seem to be the main contributors for the possible
site directly interacts with the ribosomal protein L4 in enhancement of the binding of ABT-773 to the ribosome,
a manner that possibly makes this site specific for D. compared with other 14-membered macrolides, render-
radiodurans, as explained below. ing the cladinose sugar dispensable. This is in accord
The results for both azithromycin and ABT-773 are with the observation that U → C2609EC mutations,
consistent with the majority of mutational and foot- which yield ABT-773- and telithromycin-resistant phe-
printing data [5, 18] (Figures 2–4), thus explaining the notypes, slightly increased the sensitivity to macrolides
different modes of interactions and differences in activ- like erythromycin and azithromycin, which both lack the
ity against certain MLSB-resistant phenotypes. carbamate group [18]. As proposed [18], the enhanced
potency of ABT-773 correlates with stronger interac-
ABT-773 tions of the drug, with domain II of 23S rRNA through
Ketolides derive their name from the insertion of a ke- the quinolylallyl group and with domain V through the
tone bond in the C3 position and the removal of the carbamate group.
cladinose sugar (Figure 1), which lead to a broader spec- Although the position of ABT-773 appears shifted
trum of activity against a number of erythromycin- or compared with roxithromycin or erythromycin, it shares
most of the contacts observed for these macrolides,penicillin-resistant pathogens [19–21]. In addition to the
Table 1. Data Collection Statistics
Resolution (A˚) Completeness Rsym I/(I) R Factor Rfree
ABT-773 30.0–3.50 91.8% 13.1% 7.5 28.5% 31.3%
(3.56–3.50) (88.9%) (35.8%) (2.1)
Azithromycin 30.0–3.20 86.6% 11.0% 9.0 27.9% 30.4%
(3.25–3.20) (83.4%) (33.9%) (1.9)
Numbers in parentheses denote the highest-resolution bin.
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Figure 2. Electron Density and Local Environment of ABT-773
(A) Stereo views of ABT-773 together with the 2Fo  Fc electron density map, calculated omitting ABT-773 and contoured at 1.2 .
(B) Stereo view of the local environment of ABT-773. Nucleotides contributing to hydrophobic interactions are labeled in black; those contributing
to hydrogen bonds are labeled in red.
(C) Two-dimensional sketch of interactions between ABT-773 and 23S rRNA. Nucleotides contributing to hydrophobic interactions are indicated;
those contributing to hydrogen bonds are represented by their structures.
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Figure 3. The Region of Domains II, IV, and
V of 23S rRNA that Contributes to the Binding
of ABT-773 or Azithromycin Is Shown in the
Secondary Structure Diagrams
Black circles indicate changes in nucleotide
accessibility affected by macrolides ac-
cording to biochemical data. Modifications or
mutations affecting the macrolide suscepti-
bility or resistance are indicated by arrows.
The contact sites of ABT-773 and azithro-
mycin are indicated by large, colored letters
in the diagram. The colors of the letters corre-
spond to the colors of the ligands in Figures
2 and 4.
namely, the interactions of the desosamine with coordinated through water molecules, might contribute
to the interactions through hydrogen bonds with theA2040DR (A2057EC) and A2041DR (A2058EC). This shift
cladinose sugar and the lactone ring. Since we cannotdisrupts the hydrophobic contacts with A2482DR
detect water molecules at 3.5 A˚ resolution, the potential(A2503EC) but leads to additional hydrophobic contacts
hydrogen bonds involving Mg1 have been omitted frombetween the desosamine and C2589DR (C2610EC).
Figure 4C.Interestingly, the alignment of ABT-773 with roxithro-
Surprisingly, the nitrogen inserted into the lactone ringmycin shows that the quinolylallyl of ABT-773 is in similar
does not directly contribute to the binding of azithro-position and orientation to the oxime moiety of roxithro-
mycin. It seems, however, that this modification altersmycin (Figures 5C and 5D); both point toward domain IV
the conformation of the lactone ring sufficiently to in-of 23S rRNA. Domain IV, which has not previously been
duce novel contacts to this Mg ion and C2565DR.reported to participate in the binding of ketolides, contrib-
Contrary to AZI-1, which interacts exclusively withutes to the positioning of the quinolylallyl group through
domains IV and V of 23S rRNA, AZI-2 also interacts withhydrophobic interactions of C1773DR (U1782EC). The
ribosomal proteins L4 and L22 and domain II of 23Sinteractions of the quinolylallyl group with 23S rRNA
rRNA. The main source of interactions originates fromseem to be completely independent of the type of the
hydrogen bonds between AZI-2 and the loop of L4two rRNA bases involved. Mutations in either C803DR
(Thr64 and Gly60) as well as another putative Mg ion(U790EC) or C1773DR (U1782EC) are hence not ex-
(Figure 4).pected to affect binding of ABT-773. This agrees with
Furthermore, AZI-2 makes a direct contact to AZI-1the observation that E. coli, which carries uridines in
through a hydrogen bond between its desosamine sugarboth positions (U/U), and pathogens like Heliobacter
and O1 in the lactone ring of AZI-1, which might leadpylori (U/U) and Haemophilus influenzae (A/C) are
to a synergetic enhancement of the binding of azithro-equally susceptible to ABT-773 [23, 24].
mycin. This kind of contact will probably not be possible
in 14-membered macrolides, restricting the selectivity
Azithromycin of the secondary site to 15- or 16-membered macrolides.
Azithromycin (CP-62,993 [9-deoxy-9A-methyl-9A-aza- Interestingly, the density for the lactone ring of AZI-2 is
9A-homoerythromycin]), the first member of the class considerably better resolved than that for AZI-1. This
of azalide antimicrobials, is a semisynthetic derivative might reflect the tightness of the AZI-2 binding pocket,
of erythromycin, with a 15-membered lactone ring pos- which is confined by the narrowest part of the ribosomal
sessing an additional nitrogen at position C9,10 (Figure exit tunnel, between L4 and L22, and AZI-1. The contri-
1). On examination of the electron density of the 50S- bution of L22 originates from hydrophobic interactions
azithromycin complex (Figure 4A), it was obvious that between the nonconserved Arg111 and both the cladi-
the mode of binding of azithromycin to the 50S ribo- nose and the desosamine of AZI-2. The interactions
somal subunit from D. radiodurans differs significantly between AZI-2 and L4 are more pronounced, forming
from the binding of all other macrolides studied so far. hydrogen bonding interactions between Gly60 and the
We found two azithromycin binding sites in the tunnel lactone ring as well as between the side chain of Thr64
of the 50S subunit, leading to a more extended confor- and the cladinose (Figure 4C).
mational change in the 23S rRNA. Azithromycin shares most of the interactions observed
The primary binding site of azithromycin (AZI-1) is for erythromycin, namely, the contacts with A2041DR,
located in a position and orientation similar to those of A2042DR (A2059EC), and A2045DR (A2062EC) (Figures
the other macrolides that we studied. In particular, the 3 and 4C). Only the contact with U2590DR (C2611EC)
lactone ring lies in the same plane as the lactone rings of is not present in this case, which appears to be a conse-
erythromycin, roxithromycin, clarithromycin, and ABT- quence of the conformational shift of the bulged bases
773. Bases 2045DR (A2062EC) and U2588DR (U2609EC) U2592DR (U2613EC) and A2593DR (A2614EC) of helix
contribute to the binding of AZI-1 through hydrophobic 73 (Figure 3). Because of the presence of AZI-2, the loop
connecting helices 73 and 93 is significantly shifted. Ininteractions. A putative Mg ion (Mg1), which is probably
50S Complexes with Azithromycin and ABT-773
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addition to the alteration of C803DR (U790EC) men- gen bond relies on a different orientation of the cladinose
for azithromycin compared with erythromycin. Appar-tioned above, the bases of U2588DR (U2609EC) and
G2560DR (G2581EC) reveal a distinctly different orienta- ently, the inherent flexibility of some parts of 23S rRNA
can compensate for small modifications of the antibiot-tion, G2560DR (G2581EC) being almost perpendicular
to the native conformation. ics or small alterations in the binding pattern, which
might explain the successful development of a large
number of erythromycin derivatives with strong inhibi-Discussion
tory activity.
The interaction of the second azithromycin site withThe position of ABT-773 within the PTAR appears dis-
placed by about 3 A˚ compared with the position ob- the highly conserved loop of L4 involves Tyr59, Gly63,
Thr64, and Gly60. Despite the high level of conservation,served for the macrolides of the erythromycin class (Fig-
ure 5C) but still leads to the same inhibitory mechanism, Gly60 seems to be very specific to D. radiodurans. Se-
quence alignment against all available bacterial ribo-namely, blockage of the path of the nascent chain
through the 50S subunit (Figures 5A and 5B). The posi- somal L4 proteins revealed no other bacterial organism
with a glycine present at this position. According to thetional shift seems to be induced by the interactions of
23S rRNA with the different functional groups of ABT- sequence alignment, 94% of the L4 sequences carry
either a Lys or Arg; the remaining 6% were Pro or Ala773. This is particularly apparent through the compari-
son with roxithromycin (Figures 5C and 5D). Despite the residues. Modeling a Gly60Arg mutation into the L4
structure gave rise to a short contact of 1.5 A˚ betweendifference in their positions within the 50S subunit, the
oxime extension of roxithromycin and the quinolylallyl AZI-2 and L4. This indicates that, in any other bacterial
50S subunit, the binding of AZI-2 should be altered and,of ABT-773 align very well, supporting the importance
of these functional groups for the binding of the different possibly, inhibited. Hence, the occurrence of a second-
ary binding site might be specific for D. radiodurans.macrolide derivatives.
rRNA base A752EC (C765DR) was shown to be pro- This is also supported by kinetic analysis of the binding
of azithromycin in E. coli [27], which did not reveal thetected upon binding of ketolides carrying extensions at
position C11,12 [25]. C765DR (A752EC) is in the vicinity pattern expected for a double binding site, though it was
shown earlier that macrolides like erythromycin have theof the binding site of ABT-773 but may partially contrib-
ute to the binding of the drug. However, exchanging potential to bind to ribosomal proteins L5, L21, and L4
[28].C → A765DR would possibly create a direct contact
between A765DR and ABT-773, consistent with bio- The interactions between AZI-2 and L22 exclusively
involve Arg111, which is hardly conserved. It is question-chemical data [26]. Nevertheless, it is questionable
whether this interaction would further enhance the affin- able whether this interaction is crucial for the binding
of AZI-2, but it would be interesting to see whether theity of ABT-773 for 23S rRNA, since pathogens like He-
liobacter pylori (C860, equivalent to C752EC) are equally L22 mutant described in [29] would inhibit the binding of
AZI-2 or whether azithromycin still reveals an inhibitorysusceptible to ketolides.
U → A754EC (G767DR) mutations in domain II have activity on L22-mutated ribosomes of D. radiodurans.
The conformation of the mutated L22 would certainlybeen shown to confer resistance to low levels of the
ketolide HMR3647 [22]. Since neither U754EC nor disrupt the hydrophobic contacts between Arg111 and
AZI-2 but would not block its binding site.C765EC has been found to be directly involved in bind-
ing of ABT-773 or any of the macrolides studied so far While this paper was being reviewed, the structure of
the 50S subunit from H. marismortui (H50S) in complex[2] [3], it seems that the effect of mutations of these
bases on the binding of ketolides is mediated through with azithromycin (Protein Data Bank entry 1MK1) and
three other macrolides was published [3]. The positionsmall conformational shifts affecting the loop connect-
ing helices H35a and H32. of the macrolides agrees well with our results; however,
the lactone ring was found in a rather different orienta-Whereas the binding of ABT-773 induces—with the
exception of C803DR (U790EC)—comparably small con- tion (Figure 5C). The differences in the binding pattern
are also reflected by significant differences in the localformational changes in 23S rRNA, the two azithromycin
molecules lead to more-extended shifts, particularly of RNA fold (Figure 5F). We can, as in [3], only speculate
about the reason for the significant difference in thethe single-stranded loop connecting helices 73 and 93
(Figure 3). However, most of the contacts and the bind- binding pattern. Despite the differences of interactions
for the different macrolides, especially in the case ofing mode of the primary binding site remain similar to
those observed for the macrolides. One remarkable ex- the two sites of azithromycin, all our data show a similar
orientation of the lactone ring. It appears that the differ-ception is the additional hydrogen bond between the
cladinose of AZI-1 and C2565DR (U2586EC). This hydro- ences in the binding pattern correlate with differences
Figure 4. Electron Density and Local Environment of Azithromycin
(A) Stereo view of both azithromycin molecules together with their 2Fo  Fc electron density map, calculated omitting azithromycin and
contoured at 1.5 .
(B) Stereo view of the local environment around the two azithromycin molecules. Labeling is the same as in Figure 2.
(C) Two-dimensional sketch of interactions between the two azithromycin molecules, 23S rRNA, and the ribosomal proteins L4 and L22.
Nucleotides or amino acids contributing to hydrophobic interactions are indicated; those contributing to hydrogen bonds or electrostatic
interactions are represented by their structures.
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in the experimental conditions and the local rRNA con- proposal that the binding site responsible for the antimi-
crobial activity and the one responsible for the inhibitionformation. Our cocrystals were grown in the presence
of clinically relevant concentrations of the antibiotic of 50S assembly are not identical [33] seems to agree
with the structural information. Since the binding site ofcompounds (see Experimental Procedures), whereas
extremely high-soak concentrations (1–10 mM) were the macrolides is formed by nucleotides from different
regions of 23S rRNA, it appears unlikely that this bindingused in the case of H. marismortui [3]. These high con-
centrations seem to reflect the low susceptibility of pocket will be available prior to assembly of the 50S
subunit. However, the ability of antibiotics to interactthese archea to macrolides, which might be a conse-
quence of either the extremely high salt concentrations with ribosomal proteins, which has been observed for
macrolides, tetracycline, and evernimicin, might play anand/or the different rRNA fold in the vicinity of the bind-
ing site. Particularly, the conformations of C2644HM important role in the hindrance of ribosome assembly.
The crystallographic studies presented here confirm(U2588DR) and U2621HM (C2565DR) are inconsistent
with the azithromycin position observed in D50S, since our previous results on the interactions of macrolides
with the 50S ribosomal subunit and extend the findingsthey would have led to steric clashes and disruption of
contacts between the antibiotic and 23S rRNA. Actually, to two novel classes of antibiotics, the ketolides and the
azalides. The interactions of ABT-773 and azithromycinthe orientation of the macrolides shown in [3] yields a
considerably smaller restriction of the ribosomal exit with D50S (Figure 3) correlate amazingly well with mac-
rolide and ketolide resistances as well as with changestunnel, which might suggest a comparably weaker inhib-
itory activity. in the accessibility of the 23S rRNA to chemical modifi-
cation [5]. The results emphasize the importance of the
lactone ring for the proper positioning of the corre-Biological Implications
sponding drug. However, the flexibility of the rRNA
bases interacting with the antibiotics and, also, the flexi-So far, azithromycin is the only macrolide that was found
bility of the moieties of the antibiotics involved in interac-to interact directly with two ribosomal proteins, namely,
tions with the ribosome can compensate, to some ex-L4 and L22. Despite the high evolutionary conservation
tent, for modifications or alterations. The differencesof the region of L4 involved in the binding of the second-
between the binding modes of macrolides, azalides, andary site of azithromycin, the presence of a glycine in
ketolides reveal the contributions of the chemical modi-position 60 of D. radiodurans is an almost singular event.
fications of the macrolides, on the basis of the enhancedIt is therefore possible that the results obtained for
binding properties of these compounds as well as theazithromycin are partially specific for D. radiodurans.
resistances towards these antibiotics. Such informationStudies with mutants of L4 (e.g. Gly60Arg) or antimicro-
is of fundamental importance for the design of morebial compounds blocking the secondary binding site
potent macrolides to overcome bacterial resistance.might reveal to what extent the secondary site alters
the binding of the primary binding site of azithromycin.
Experimental Procedures
The secondary AZI binding site does not appear to
be responsible for the resistance mechanism against Base and Amino Acid Numbering
Nucleotides named [ACGU]nnnnDR, [ACGU]nnnnEC, or [AC-macrolides induced by mutations in L4 and L22, which
GU]nnnnHM are numbered according to the D. radiodurans, E. coli,were identified almost 30 years ago [30]. We did not
or H. marismortui 23S rRNA sequences, respectively. Amino acidsobserve a secondary binding site for any of the 14-
are always numbered according to the D. radiodurans sequences.membered macrolides bound to the D50S subunit. But,
23S rRNA sequence alignments were based on the 2D structure
even if there were two binding sites of erythromycin in diagrams obtained from http://www.rna.icmb.texas.edu [34].
E. coli, the locations of the mutations are too far from
the residues interacting with AZI-2 to yield a plausible 50S Crystals
Crystals of the 50S ribosomal subunit were obtained as previouslyresistance mechanism. Hence, our results support the
described [2, 35]. Cocrystallization was carried out in the presenceidea that the resistance acquired from the mutations in
of 7-fold excesses of azithromycin or ABT-773.L4 and L22 in E. coli result from conformational changes
induced by these mutations [29, 31].
X-Ray Diffraction
It has been shown that ABT-773 and azithromycin, as Data were collected at 85 K from shock-frozen crystals with a syn-
well as other ketolides and macrolides, inhibit the in chrotron radiation beam at ID19 at Argonne Photon Source/Argonne
National Laboratory (APS/ANL) and at ID14/2 and ID14/4 at thevivo assembly of the 50S ribosomal subunit [32]. The
Figure 5. Comparison between Several Structures of Liganded and Native 50S
(A) Overview of the 50S subunit from D. radiodurans (D50S) and the bound antibiotics with the axis of the ribosomal exit tunnel perpendicular
to the plane.
(B) Enlarged detail of the tunnel with antibiotics. Colors are chosen as in (A).
(C) Comparison of the positions of ABT-773 and roxithromycin (top), AZI-1 and roxithromycin (middle), and AZI-1 and the corresponding
molecule of azithromycin in the 50S subunit from H. marismortui [3] as deposited in the Protein Data Bank (1MK1) (bottom). The left column
shows the antibiotics in an orientation similar to those in (A) and (B). The right column shows a view rotated by approximately 90o.
(D) The local structures of the complexes of D50S with ABT-773 and roxithromycin.
(E) The local structures of the complexes of D50S with azithromycin and roxithromycin. AZI-2 has been omitted.
(F) The local structures of the complexes of D50S and H50S with azithromycin [3]. AZI-2 has been omitted. For the sake of clarity, small parts
of the local structures shown in (D) and (E) have been omitted.
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European Synchrotron Radiation Facility/European Molecular Biol- new class of macrolide antibiotics, the azalides. J. Antibiot. 41,
1029–1047.ogy Laboratory (ESRF/EMBL). Data were recorded on Quantum 4
or APS-CCD detectors and processed with HKL2000 [36] and the 7. Agouridas, C., Denis, A., Auger, J.M., Benedetti, Y., Bonnefoy,
A., Bretin, F., Chantot, J.F., Dussarat, A., Fromentin, C., D’Am-CCP4 suite [37].
brieres, S.G., et al. (1998). Synthesis and antibacterial activity
of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a newLocalization and Refinement
class of antibacterials highly potent against macrolide-resistantThe 3.0 A˚ structure of the 50S subunit (Protein Data Bank accession
and -susceptible respiratory pathogens. J. Med. Chem. 41,code 1LNR) was refined against the structure factor amplitudes of
4080–4100.each of the two 50S-antibiotic complexes, by rigid-body refinement
8. Montenez, J.P., Van Bambeke, F., Piret, J., Brasseur, R., Tul-as implemented in CNS [38]. For the calculation of the free R factor,
kens, P.M., and Mingeot-Leclercq, M.P. (1999). Interactions of7% of the data were omitted during refinement. The positions of the
macrolide antibiotics (erythromycin A, roxithromycin, erythro-antibiotics were readily determined from sigma-weighted difference
mycylamine [dirithromycin], and azithromycin) with phospholip-maps. The superior quality of the difference maps, showing the
ids: computer-aided conformational analysis and studies onhole of the lactone ring, revealed unambiguously the position and
acellular and cell culture models. Toxicol. Appl. Pharmacol. 156,orientation of the lactone ring. The electron density for the second
129–140.binding site of azithromycin (see Figure 4A) indicated a small confor-
9. Savage, P.B. (2001). Multidrug-resistant bacteria: overcomingmational change in the lactone ring, but these differences are con-
antibiotic permeability barriers of gram-negative bacteria. Ann.siderably smaller than the average coordinate error (about 0.7 A˚
Med. 33, 167–171.according to Luzzati plots). Therefore, we did not attempt to model
10. Vaara, M. (1993). Outer-membrane permeability barrier tothe presumed conformational change.
azithromycin, clarithromycin, and roxithromycin in gram-nega-
tive enteric bacteria. Antimicrob. Agents Chemother. 37,Coordinates and Figures
354–356.Antibiotic compounds and corresponding ligand structures were
11. Rakita, R.M., Jacquespalaz, K., and Murray, B.E. (1994). Intra-made available by Abbott Laboratories for ABT-773 and by Pliva
cellular activity of azithromycin against bacterial enteric patho-(Croatia) for azithromycin. Three-dimensional figures were produced
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